These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21906509)

  • 21. Cost-effectiveness of a combined classroom curriculum and parental intervention: economic evaluation of data from the Steps Towards Alcohol Misuse Prevention Programme cluster randomised controlled trial.
    Agus A; McKay M; Cole J; Doherty P; Foxcroft D; Harvey S; Murphy L; Percy A; Sumnall H
    BMJ Open; 2019 Jul; 9(7):e027951. PubMed ID: 31270116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the costs of school-based mouthrinsing programs.
    Doherty NJ; Martie CW
    Community Dent Oral Epidemiol; 1987 Apr; 15(2):67-9. PubMed ID: 3471378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are adolescents with high socioeconomic status more likely to engage in alcohol and illicit drug use in early adulthood?
    Humensky JL
    Subst Abuse Treat Prev Policy; 2010 Aug; 5():19. PubMed ID: 20687935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the association between the strength of state policies on school drug prevention and substance use disorders.
    Welsh JW; Hou SS; Shentu Y; Lê Cook B
    Subst Use Misuse; 2019; 54(5):811-817. PubMed ID: 30574799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taking a School-Based Child Sexual Abuse Prevention Program to Scale: a Cost Analysis.
    Shipe SL; Guastaferro K; Noll JG; Connell CM; Morgan PL; Crowley DM
    Prev Sci; 2022 Nov; 23(8):1394-1403. PubMed ID: 35867317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness evaluation of the school-based drug prevention program #Tamojunto in Brazil: 21-month follow-up of a randomized controlled trial.
    Sanchez ZM; Valente JY; Sanudo A; Pereira APD; Schneider DR; Andreoni S
    Int J Drug Policy; 2018 Oct; 60():10-17. PubMed ID: 30081337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unit Costs of Delinquent Acts for Use in Economic Evaluations.
    Reckers-Droog VT; Goorden M; Dijkgraaf MGW; Van Eeren HV; McCollister KE; Hakkaart-van Roijen L
    J Ment Health Policy Econ; 2019 Jun; 22(2):71-79. PubMed ID: 31319377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of school-located influenza vaccination programs for elementary and secondary school children.
    Yoo BK; Schaffer SJ; Humiston SG; Rand CM; Goldstein NPN; Albertin CS; Concannon C; Szilagyi PG
    BMC Health Serv Res; 2019 Jun; 19(1):407. PubMed ID: 31234842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NARCONON drug education curriculum for high school students: a non-randomized, controlled prevention trial.
    Lennox RD; Cecchini MA
    Subst Abuse Treat Prev Policy; 2008 Mar; 3():8. PubMed ID: 18348735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial.
    Crowley DM; Jones DE; Coffman DL; Greenberg MT
    Prev Med; 2014 May; 62():71-7. PubMed ID: 24521531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Project Towards No Drug Abuse: generalizability to a general high school sample.
    Dent CW; Sussman S; Stacy AW
    Prev Med; 2001 Jun; 32(6):514-20. PubMed ID: 11394955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention Harmful Consumption of Alcohol and Drugs in Sao Tome and Principe Through Public Health Communication: The Scientific Protocol].
    De Santiago I; Nicolau LB; Marinho RT; Pereira-Miguel J
    Acta Med Port; 2020 Apr; 33(4):229-236. PubMed ID: 32238236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a family-based substance abuse prevention program targeted for the middle school years.
    Abbey A; Pilgrim C; Hendrickson P; Buresh S
    J Drug Educ; 2000; 30(2):213-28. PubMed ID: 10920600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spreading the word: A process evaluation of a voluntary AOD prevention program.
    Edelen MO; Tucker J; D'Amico E
    Am J Addict; 2015 Jun; 24(4):315-22. PubMed ID: 25846206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic Evaluation of a Sun Protection Promotion Program in California Elementary Schools.
    Meenan RT; Reynolds KD; Buller DB; Massie K; Berteletti J; Buller MK; Ashley J; Liu X
    Am J Health Promot; 2020 Nov; 34(8):848-856. PubMed ID: 32054287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol and drug abuse prevention in Wisconsin public schools.
    Fredisdorf M
    J Sch Health; 1989 Jan; 59(1):21-4. PubMed ID: 2927086
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.